• Top Picks
    • XGEVA® Mechanism of Action Video Challenge
    • Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates
    • Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC
    • New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

Select a Topic

  • FILTER BY:
  • All Education Lab
  • CME Only
XGEVA® Mechanism of Action Video Challenge
VIDEO

XGEVA® Mechanism of Action Video Challenge

This activity is sponsored as an educational service by Amgen.

October 29, 2014

Learn about the mechanism of action of XGEVA®…

go to activity»
Treatment Decision-Making through the Spectrum of MDS:                                                                   Case 1 Low Risk MDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS to patients and their families. This program reviews communication strategies…

go to activity»
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes
CME

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

Expiration Date: 8/15/2015
Credit Type(s): CME | Credit: 1.5

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances have shown that 70% of cases are the result of inherited traits. Hemophilia A,…

go to activity»
Treatment Decision-Making through the Spectrum of MDS:                                  Case 2 High Risk MDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to patients and their families. This program reviews communication strategies that…

go to activity»
Treatment Decision-Making through the Spectrum of MDS:                                  Case 3 Stem Cell Transplant for MDS
CMECNE

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

Expiration Date: 7/31/2015
Credit Type(s): CME / CNE | Credit: 0.5

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to patients and their families. This program reviews communication strategies that…

go to activity»
Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates
CME

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 8/15/2015
Credit Type(s): CME | Credit: 1

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in development, with the hope of dramatically improving outcomes for patients…

go to activity»
morganatic-roan